# MicroRNA Activation of LOX-1 Mechanisms in Endometriosis

> **NCT05331053** · PHASE4 · TERMINATED · sponsor: **Penn State University** · enrollment: 6 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT05331053
- **Lead sponsor:** Penn State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2024-08-31
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** COVID halting human subjects research and preliminary data from this proposal were used to submit an NIH grant. The NIH grant was funded and 3 other protocols were launched.
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05331053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05331053, "MicroRNA Activation of LOX-1 Mechanisms in Endometriosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05331053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*